tirzepatide surmount-1 weight loss percent 72 weeks Adults with obesity using maintain 'remarkable' at 88 Semaglutide vs. Tirzepatide: Which GLP-1

Furthermore, semaglutide can also support patients in maintaining their results post-surgery

These treatments have several limitations regarding their clinical application

[27] and Gejl et al

Patients should understand the expected pace of results, possible side effects, and the importance of not adjusting dose without medical guidance

These include, but are not limited to: Your specific UHC plan The drug tier in which Rybelsus is categorized on your plans formulary Whether or not you have a Type 2 diabetes diagnosis Whether or not your healthcare provider can provide documentation for prior authorization Bottom line: Every UHC plan is different